December 14, 2025
  • Facebook
  • Twitter
  • LinkedIn

BiomolBiomed Viewpoints

Science in plain words

  • Home
  • News
  • About
    • BiomolBiomed Viewpoints
    • BiomolBiomed Journal
  • Journal Website
  • Reviews
  • pathology
  • microbiology
  • immunology
  • translational medicine
  • genetics
  • biochemistry
  • anatomy
  • molecular biology
  • clinical medicine
  • new methods
  • new medical entities
Latest posts
  • [ December 12, 2025 ] How Tumors Rewire Glucose Metabolism to Escape Copper-Induced Cell Death Author Summary
  • [ December 10, 2025 ] Presepsin Shows Strong Potential for Improving Sepsis Diagnosis Author Summary
  • [ December 10, 2025 ] The Reviewer of the Month for December 2025: Marko Bojović, MD Reviewer of the Month
  • [ December 8, 2025 ] Sugammadex vs. Neostigmine: New Evidence on Post-Anesthesia Recovery Author Summary
  • [ December 5, 2025 ] How Gut Microbial Metabolites Impact Alzheimer’s Disease: Insights into the Brain-Gut Axis Author Summary
Home医学

医学

NEIL3 and TOP2A drive esophageal cancer through WNT signaling
Author Summary

NEIL3 and TOP2A drive esophageal cancer through WNT signaling

April 8, 2025 0

A Silent Killer with Limited Treatment Options Esophageal cancer (EC) is one of the deadliest cancers, ranking among the leading causes of cancer-related deaths worldwide. It begins in the lining of the esophagus and is […]

BiomolBiomed journal metrics

  • Impact Factor 2024 (JCR®): 2.2
  • CiteScore 2024 (Scopus): 5.2
  • Google Scholar Citations
  • Dimensions metrics

See more here…

BiomolBiomed Newsletters

Subscribe to receive the latest content and news from Biomolecules and Biomedicine. Choose from our sections or themes of your interest.

Categories

  • Author Summary
  • Conferences
  • Interview
  • News
  • Opinion
  • Reviewer of the Month
  • Topics
  • Video Summary

Archives

TELL US

What matters the most when choosing the journal to submit your article?
Vote
Follow us on Facebook

Copyright (c) 2021 Association of Basic Medical Sciences of FBIH

 

Loading Comments...